Chicago biotech-focused VC firm Arch Venture Partners closes $3 billion fund

[ad_1]

A biotech-focused venture capital firm in Chicago is ready with a new fund as life sciences and biotech continue to find new life in Chicago.

[ad_2]

ReportWire